Archive ready

医薬品医療機器等法違反業者に対する自治体による行政処分について（第２報）｜厚生労働省

https://www.mhlw.go.jp/stf/houdou/0000154867.html

April 4, 2026 at 03:30 AM JST•The archive page, viewer, and downloads use this saved version.

April 4, 2026 at 03:30 AM JST·www.mhlw.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

医薬品医療機器等法違反業者に対する自治体による行政処分について（第２報）｜厚生労働省

Open the archived HTML with saved-time metadata attached.

Original URLhttps://www.mhlw.go.jp/stf/houdou/0000154867.html

StartedApril 4, 2026 at 03:30 AM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page announces administrative measures taken by Tokyo and Osaka against wholesale pharmaceutical distributors regarding counterfeit C-type hepatitis treatment drug "Harvoni Combination Tablets." On March 13, 2017, Tokyo issued improvement orders to five companies: Yell Pharmaceutical, Daiko Pharmaceutical, Takayo Pharmaceutical, Fuji Pharmaceutical, and Nogawa Pharmaceutical. Osaka issued an order to Global Net Ells. All orders were based on the Pharmaceutical Affairs Law Article 72-4, Paragraph 1, to ensure product quality, efficacy, and safety.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.